In this episode, Erica Jackson discusses recent guidance from the Food & Drug Administration (FDA) on the consideration of real-world data and real-world evidence in regulatory decision-making related to medical devices and their development. The episode notes stakeholders should work closely with the FDA so that real-world data collected and maintained during the development process is high quality, relevant, reliable, and stored with the appropriate privacy and data security protections.

Click here to listen to the podcast.